Atlas Trials

A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy

Clinical trial NCT00261677 · COMPLETED

Trial details

NCT number
NCT00261677
Sponsor
Ortho Biotech Products, L.P.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
AnemiaHodgkin DiseaseLeukemiaLymphoma, Non-hodgkin
Start date
2000-08-01
Enrollment
224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.